Bing‐Hui Yang
Papers
1
Total Citations
2
H-Index
1
About
Bing-Hui Yang is a pioneering researcher in biomedical micro-robotics and targeted cancer therapy, with a primary focus on osteosarcoma treatment. Their most notable contribution is the development of magnetically driven hydrogel microrobots designed to enhance the therapeutic efficacy of anlotinib, a drug used against osteosarcoma—a bone cancer with high mortality and limited treatment options due to its complex genetics and lack of specific membrane receptors. This innovative work, published in 2024 and already garnering 2 citations, addresses the critical challenge of active targeting in cancer therapy. By engineering these microrobots to be precisely controlled via magnetic fields, Yang has opened new avenues for delivering drugs directly to tumor sites, potentially overcoming the barriers of conventional targeted therapies. Their research stands at the intersection of materials science, robotics, and oncology, offering a promising strategy to improve treatment outcomes for patients with osteosarcoma. Yang’s work exemplifies how interdisciplinary approaches can tackle difficult medical problems, making them a rising figure in the field of nanomedicine and drug delivery systems.
Research Focus
Key Achievements
Top Papers
- 1